Concentration of Insulin-Like Growth Factor (IGF)-I in Iliac Crest Bone Matrix in Premenopausal Women with Idiopathic Osteoporosis

Abstract

Previous studies have shown a link between low serum insulin-like growth factor-I (IGF-I) and decreased bone mass of patients with osteoporosis. However, whether serum levels are representative for the growth factor concentration or activity available in human bone tissue is controversial. In the present study, IGF-I was assessed in serum and bone matrix extracts from the iliac crest in 19 eugonadal women with idiopathic osteoporosis and in 38 age-matched controls. In addition, the relationship between the skeletal levels of IGF-I and bone mineral density (BMD) or the susceptibility to osteoporotic fractures in women with osteoporosis was examined. Bone matrix extraction was performed based on a guanidine-HCL/ethylendiamine-tetraacetic acid (EDTA) method. No significant difference in both serum and bone matrix IGF-I levels between groups was observed. Serum IGF-I concentrations failed to be associated with bone matrix IGF-I levels in osteoporotic patients. However, in premenopausal women with idiopathic osteoporosis, skeletal IGF-I positively correlated with BMD at the lumbar spine (r = + 0.58, p = 0.01). In contrast, neither femoral neck BMD nor Ward's triangle BMD was associated with bone matrix IGF-I concentrations. A tendency towards lower levels of bone matrix IGF-I in subjects with vertebral fractures as compared to those without fractures was observed in age-adjusted analyses, however the difference failed to remain statistically significant after adjustment for bone mineral density. These data provide no clear evidence for low bone matrix IGF-I as a determinant factor of age-unrelated osteoporosis. However, low skeletal IGF-I concentrations may aggravate osteoporosis in these women.

Insulin-like growth factor-I - osteoporosis - bone matrix - bone mineral density

References

• 1 Barrett-Connor E, Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study.  J Bone Miner Res. 1998;  13 1343-1349
• 2 Bautista C M, Mohan S, Baylink D J. Insulin-like growth factors I and II are present in the skeletal tissue of ten vertebrates.  Metabolism. 1991;  39 96-100
• 3 Blum W F, Ranke M B, Bierich J R. A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.  Acta Endocrinol (Copenh). 1988;  118 374-380
• 4 Blum W F, Ranke M B, Bierich J R. Radioimmunoassay for IGFs and IGFBPs.  Growth Regul. 1994;  4 (Suppl 1) 11-19
• 5 Boonen S, Aersness J, Dequeker J, Nicholson P, Cheng X, Lowet G, Verbeke G, Bouillon R. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: potential implications for age-related (type II) osteoporotic fracture occurrence.  Calcif Tissue Int. 1997;  61 173-178
• 6 Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R. Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss.  J Am Geriatr Soc. 1996;  44 1301-1306
• 7 Calo L, Castrignano R, Davis P A, Carraro G, Pagnin E, Giannini S, Semplicini A, D'Angelo A. Role of insulin-like growth factor-I in primary osteoporosis: a correlative study.  J Endocrinol Invest. 2000;  23 223-227
• 8 Celiker R, Arslan S. Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic postmenopausal women.  Rheumatol Int. 2000;  19 205-208
• 9 Clemmons D, Van Wyck J. Factors controlling blood concentration of somatomedin.  J Clin Endocrinol Metab. 1984;  13 113-143
• 10 Daughaday W H, Rotwein P. Insulin-like growth factors I and II. Peptide messenger ribonucleic acid and gene structures, serum, and tissue concentrations.  Endocr Rev. 1989;  10 68-91
• 11 Dequeker J, Pearson J, Reeve J, Henley M, Bright J, Felsenberg D, Kalender W, Laval-Jeantet A M, Ruegsegger P, Adams J. et al . Dual X ray absorptiometry-cross-calibration and normative reference ranges for the spine: results of a European Community Concerted Action.  Bone. 1995;  17 247-254
• 12 Erdmann J, Storch S, Pfeilschifter J, Ochlich P, Ziegler R, Bauss F. Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix.  Bone. 1998;  22 503-507
• 13 Gamero P, Sornay-Rendu E, Delmas P D. Low serum IGF-I and occurrence of osteoporotic fractures in postmenopausal women.  Lancet. 2000;  11 898-899
• 14 Hankinson S E, Willet W C, Colditz G A, Hunter D J, Michaud D S, Deroo B, Rosner B, Speizer F E, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.  Lancet. 1998;  351 1393-1396
• 15 Hauschka P V, Mavrakos A E, Iafrati M D, Doleman S E, Klagsbrun M. Growth factors in bone matrix: isolation of multiple types by affinity chromatography on heparin-sepharose.  J Biol Chem. 1986;  261 12665-12674
• 16 Hock J, Centrella M, Canalis E. Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication.  Endocrinology. 1988;  122 254-260
• 17 Janssen J AJML, Burger H, Stolk R P, Grobbee D E, de Jong F H, Lamberts S WJ, Pols H AP. Gender-specific relationships between serum free and total IGF-I and bone mineral density in elderly men and women.  Eur J Endocrinol. 1998;  138 627-632
• 18 Ljunghall S, Johansson A G, Burman P, Kampe O, Lindh E, Karlsson F A. Low plasma levels of insulin-like growth factor I in male patients with idiopathic osteoporosis.  J Int Med. 1992;  232 59-64
• 19 Malpe R, Baylink D J, Linkhart T A, Wergedal J E, Mohan S. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4 and -5 levels in conditioned media of normal human bone cells are skeletal site-dependent.  J Bone Miner Res. 1997;  9 1999-2005
• 20 Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R. Influence of insulin-like growth factor-I and leptin on bone mass in healthy postmenopausal women.  Bone. 2001;  28 113-117
• 21 Milne M, Kang M, Quail J M, Baran D T. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.  Endocrinology. 1998;  139 2527-2533
• 22 Nicolas V, Mohan S, Honda Y, Prewett A, Finkelman R D, Baylink D J, Farley J R. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.  Calcif Tissue Int. 1995;  57 206-212
• 23 Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman R D, Baylink D J, Farley J R. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging.  J Clin Endocrinol Metab. 1994;  78 1011-1016
• 24 Overall C M. A microtechnique for dialysis of small volume solutions with quantitative recoveries.  Anal Biochem. 1987;  165 208-214
• 25 Pfeilschifter J, Laukhuf F, Muller-Beckmann B, Blum W F, Pfister T, Ziegler R. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.  J Clin Invest. 1995;  96 767-774
• 26 Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge H W, Blum W E, Wüster C, Haack D, Ziegler R. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women.  J Clin Endocrinol Metab. 1996;  81 2534-2540
• 27 Reed B Y, Zerwekh J E, Sakhaee K, Breslau N A, Gottschalk F, Pak C YC. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis.  J Bone Min Res. 1995;  10 1218-1224
• 28 Rosen C J, Dimai H P, Vereault D, Donahue L R, Beamer W G, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink D J. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.  Bone. 1997;  21 217-223
• 29 Rosen C J, Kurland E S, Vereault D, Adler R A, Rackoff P J, Craig W Y, Witte S, Rogers J, Bilezikian J P. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.  J Clin Endocrinol Metab. 1998;  83 2286-2290
• 30 Rudman D, Drinka P J, Wilson C R, Mattson D E, Scherman F, Cuisinier M C, Schultz S. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men.  Clin Endocrinol. 1994;  40 653-661
• 31 Seck T, Bretz A, Krempien R, Krempien B, Ziegler R, Pfeilschifter J. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass.  Bone. 1999;  24 387-393
• 32 Seck T, Scheppach B, Scharla S, Diel I, Blum W F, Bismar H, Schmid G, Krempien B, Ziegler R, Pfeilschifter J. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.  J Clin Endocrinol Metab. 1998;  83 2331-2337
• 33 Sugimoto T, Nishiyama K, Kuribay A, Chihara K. Serum levels of insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-2 and IGFBP-3 in osteoporotic patients with and without spinal fractures.  J Bone Miner Res. 1997;  12 1272-1279
• 34 Swedish Council on Technology Assessment in Health Care . Bone density measurement: a systematic review.  J Int Med. 1997;  241 (Suppl 739) 12-22
• 35 Wüster C, Blum W, Schlemilch S, Ranke M B, Ziegler R. Decreased insulin-like growth factors and IGF-binding protein 3 in osteoporosis.  J Int Med. 1993;  234 249-255